Protein Triggers Immune Response in Lupus Patients

The researchers are now collaborating with rheumatologists to explore this potential therapy. A starting point will be analyzing how levels of MAVS oligomerization and type I IFN response change in antioxidant therapy.

Be the first to comment

Leave a Reply

Your email address will not be published.